The Immunoassays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Immunoassays market size is estimated to be worth US$ 23420 million in 2021 and is forecast to a readjusted size of USD 30170 million by 2028 with a CAGR of 3.7% during review period. Hospital accounting for % of the Immunoassays global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Enzyme Immunoassay segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Immunoassays include Abbott, BD, Danaher, Devon Medical Products, and EDP Biotech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunoassays market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Enzyme Immunoassay
Fluorescence Immunoassay
Chemiluminescence Immunoassay
Radioimmunoassay
Nephelometric Immunoassay
Market segment by Application, can be divided into
Hospital
Centralized Laboratory
Academic Institution
Pharma & Biotech Firm
Contract Research Organization
Other
Market segment by players, this report covers
Abbott
BD
Danaher
Devon Medical Products
EDP Biotech
Hologic
Luminex
Meridian Life Science
QIAGEN
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Immunoassays product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Immunoassays, with revenue, gross margin and global market share of Immunoassays from 2019 to 2022.
Chapter 3, the Immunoassays competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Immunoassays market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Immunoassays research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Immunoassays
1.2 Classification of Immunoassays by Type
1.2.1 Overview: Global Immunoassays Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Immunoassays Revenue Market Share by Type in 2021
1.2.3 Enzyme Immunoassay
1.2.4 Fluorescence Immunoassay
1.2.5 Chemiluminescence Immunoassay
1.2.6 Radioimmunoassay
1.2.7 Nephelometric Immunoassay
1.3 Global Immunoassays Market by Application
1.3.1 Overview: Global Immunoassays Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Centralized Laboratory
1.3.4 Academic Institution
1.3.5 Pharma & Biotech Firm
1.3.6 Contract Research Organization
1.3.7 Other
1.4 Global Immunoassays Market Size & Forecast
1.5 Global Immunoassays Market Size and Forecast by Region
1.5.1 Global Immunoassays Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Immunoassays Market Size by Region, (2017-2022)
1.5.3 North America Immunoassays Market Size and Prospect (2017-2028)
1.5.4 Europe Immunoassays Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Immunoassays Market Size and Prospect (2017-2028)
1.5.6 South America Immunoassays Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Immunoassays Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunoassays Market Drivers
1.6.2 Immunoassays Market Restraints
1.6.3 Immunoassays Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Immunoassays Product and Solutions
2.1.4 Abbott Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Recent Developments and Future Plans
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Immunoassays Product and Solutions
2.2.4 BD Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BD Recent Developments and Future Plans
2.3 Danaher
2.3.1 Danaher Details
2.3.2 Danaher Major Business
2.3.3 Danaher Immunoassays Product and Solutions
2.3.4 Danaher Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Danaher Recent Developments and Future Plans
2.4 Devon Medical Products
2.4.1 Devon Medical Products Details
2.4.2 Devon Medical Products Major Business
2.4.3 Devon Medical Products Immunoassays Product and Solutions
2.4.4 Devon Medical Products Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Devon Medical Products Recent Developments and Future Plans
2.5 EDP Biotech
2.5.1 EDP Biotech Details
2.5.2 EDP Biotech Major Business
2.5.3 EDP Biotech Immunoassays Product and Solutions
2.5.4 EDP Biotech Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 EDP Biotech Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Immunoassays Product and Solutions
2.6.4 Hologic Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Luminex
2.7.1 Luminex Details
2.7.2 Luminex Major Business
2.7.3 Luminex Immunoassays Product and Solutions
2.7.4 Luminex Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Luminex Recent Developments and Future Plans
2.8 Meridian Life Science
2.8.1 Meridian Life Science Details
2.8.2 Meridian Life Science Major Business
2.8.3 Meridian Life Science Immunoassays Product and Solutions
2.8.4 Meridian Life Science Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Meridian Life Science Recent Developments and Future Plans
2.9 QIAGEN
2.9.1 QIAGEN Details
2.9.2 QIAGEN Major Business
2.9.3 QIAGEN Immunoassays Product and Solutions
2.9.4 QIAGEN Immunoassays Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 QIAGEN Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Immunoassays Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Immunoassays Players Market Share in 2021
3.2.2 Top 10 Immunoassays Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Immunoassays Players Head Office, Products and Services Provided
3.4 Immunoassays Mergers & Acquisitions
3.5 Immunoassays New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Immunoassays Revenue and Market Share by Type (2017-2022)
4.2 Global Immunoassays Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Immunoassays Revenue Market Share by Application (2017-2022)
5.2 Global Immunoassays Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Immunoassays Revenue by Type (2017-2028)
6.2 North America Immunoassays Revenue by Application (2017-2028)
6.3 North America Immunoassays Market Size by Country
6.3.1 North America Immunoassays Revenue by Country (2017-2028)
6.3.2 United States Immunoassays Market Size and Forecast (2017-2028)
6.3.3 Canada Immunoassays Market Size and Forecast (2017-2028)
6.3.4 Mexico Immunoassays Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Immunoassays Revenue by Type (2017-2028)
7.2 Europe Immunoassays Revenue by Application (2017-2028)
7.3 Europe Immunoassays Market Size by Country
7.3.1 Europe Immunoassays Revenue by Country (2017-2028)
7.3.2 Germany Immunoassays Market Size and Forecast (2017-2028)
7.3.3 France Immunoassays Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Immunoassays Market Size and Forecast (2017-2028)
7.3.5 Russia Immunoassays Market Size and Forecast (2017-2028)
7.3.6 Italy Immunoassays Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Immunoassays Revenue by Type (2017-2028)
8.2 Asia-Pacific Immunoassays Revenue by Application (2017-2028)
8.3 Asia-Pacific Immunoassays Market Size by Region
8.3.1 Asia-Pacific Immunoassays Revenue by Region (2017-2028)
8.3.2 China Immunoassays Market Size and Forecast (2017-2028)
8.3.3 Japan Immunoassays Market Size and Forecast (2017-2028)
8.3.4 South Korea Immunoassays Market Size and Forecast (2017-2028)
8.3.5 India Immunoassays Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Immunoassays Market Size and Forecast (2017-2028)
8.3.7 Australia Immunoassays Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Immunoassays Revenue by Type (2017-2028)
9.2 South America Immunoassays Revenue by Application (2017-2028)
9.3 South America Immunoassays Market Size by Country
9.3.1 South America Immunoassays Revenue by Country (2017-2028)
9.3.2 Brazil Immunoassays Market Size and Forecast (2017-2028)
9.3.3 Argentina Immunoassays Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Immunoassays Revenue by Type (2017-2028)
10.2 Middle East & Africa Immunoassays Revenue by Application (2017-2028)
10.3 Middle East & Africa Immunoassays Market Size by Country
10.3.1 Middle East & Africa Immunoassays Revenue by Country (2017-2028)
10.3.2 Turkey Immunoassays Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Immunoassays Market Size and Forecast (2017-2028)
10.3.4 UAE Immunoassays Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Immunoassays Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Immunoassays Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Immunoassays Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Immunoassays Revenue (USD Million) by Region (2017-2022)
Table 5. Global Immunoassays Revenue Market Share by Region (2023-2028)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Immunoassays Product and Solutions
Table 9. Abbott Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BD Corporate Information, Head Office, and Major Competitors
Table 11. BD Major Business
Table 12. BD Immunoassays Product and Solutions
Table 13. BD Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Danaher Corporate Information, Head Office, and Major Competitors
Table 15. Danaher Major Business
Table 16. Danaher Immunoassays Product and Solutions
Table 17. Danaher Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Devon Medical Products Corporate Information, Head Office, and Major Competitors
Table 19. Devon Medical Products Major Business
Table 20. Devon Medical Products Immunoassays Product and Solutions
Table 21. Devon Medical Products Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. EDP Biotech Corporate Information, Head Office, and Major Competitors
Table 23. EDP Biotech Major Business
Table 24. EDP Biotech Immunoassays Product and Solutions
Table 25. EDP Biotech Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Hologic Corporate Information, Head Office, and Major Competitors
Table 27. Hologic Major Business
Table 28. Hologic Immunoassays Product and Solutions
Table 29. Hologic Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Luminex Corporate Information, Head Office, and Major Competitors
Table 31. Luminex Major Business
Table 32. Luminex Immunoassays Product and Solutions
Table 33. Luminex Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Meridian Life Science Corporate Information, Head Office, and Major Competitors
Table 35. Meridian Life Science Major Business
Table 36. Meridian Life Science Immunoassays Product and Solutions
Table 37. Meridian Life Science Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 39. QIAGEN Major Business
Table 40. QIAGEN Immunoassays Product and Solutions
Table 41. QIAGEN Immunoassays Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Immunoassays Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Immunoassays Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Immunoassays by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Immunoassays Players Head Office, Products and Services Provided
Table 46. Immunoassays Mergers & Acquisitions in the Past Five Years
Table 47. Immunoassays New Entrants and Expansion Plans
Table 48. Global Immunoassays Revenue (USD Million) by Type (2017-2022)
Table 49. Global Immunoassays Revenue Share by Type (2017-2022)
Table 50. Global Immunoassays Revenue Forecast by Type (2023-2028)
Table 51. Global Immunoassays Revenue by Application (2017-2022)
Table 52. Global Immunoassays Revenue Forecast by Application (2023-2028)
Table 53. North America Immunoassays Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Immunoassays Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Immunoassays Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Immunoassays Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Immunoassays Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Immunoassays Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Immunoassays Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Immunoassays Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Immunoassays Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Immunoassays Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Immunoassays Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Immunoassays Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Immunoassays Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Immunoassays Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Immunoassays Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Immunoassays Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Immunoassays Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Immunoassays Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Immunoassays Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Immunoassays Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Immunoassays Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Immunoassays Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Immunoassays Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Immunoassays Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Immunoassays Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Immunoassays Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Immunoassays Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Immunoassays Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Immunoassays Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Immunoassays Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Immunoassays Picture
Figure 2. Global Immunoassays Revenue Market Share by Type in 2021
Figure 3. Enzyme Immunoassay
Figure 4. Fluorescence Immunoassay
Figure 5. Chemiluminescence Immunoassay
Figure 6. Radioimmunoassay
Figure 7. Nephelometric Immunoassay
Figure 8. Immunoassays Revenue Market Share by Application in 2021
Figure 9. Hospital Picture
Figure 10. Centralized Laboratory Picture
Figure 11. Academic Institution Picture
Figure 12. Pharma & Biotech Firm Picture
Figure 13. Contract Research Organization Picture
Figure 14. Other Picture
Figure 15. Global Immunoassays Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Immunoassays Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Immunoassays Revenue Market Share by Region (2017-2028)
Figure 18. Global Immunoassays Revenue Market Share by Region in 2021
Figure 19. North America Immunoassays Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Immunoassays Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Immunoassays Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Immunoassays Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Immunoassays Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Immunoassays Market Drivers
Figure 25. Immunoassays Market Restraints
Figure 26. Immunoassays Market Trends
Figure 27. Abbott Recent Developments and Future Plans
Figure 28. BD Recent Developments and Future Plans
Figure 29. Danaher Recent Developments and Future Plans
Figure 30. Devon Medical Products Recent Developments and Future Plans
Figure 31. EDP Biotech Recent Developments and Future Plans
Figure 32. Hologic Recent Developments and Future Plans
Figure 33. Luminex Recent Developments and Future Plans
Figure 34. Meridian Life Science Recent Developments and Future Plans
Figure 35. QIAGEN Recent Developments and Future Plans
Figure 36. Global Immunoassays Revenue Share by Players in 2021
Figure 37. Immunoassays Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Immunoassays Revenue Market Share in 2021
Figure 39. Global Top 10 Players Immunoassays Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Immunoassays Revenue Share by Type in 2021
Figure 42. Global Immunoassays Market Share Forecast by Type (2023-2028)
Figure 43. Global Immunoassays Revenue Share by Application in 2021
Figure 44. Global Immunoassays Market Share Forecast by Application (2023-2028)
Figure 45. North America Immunoassays Sales Market Share by Type (2017-2028)
Figure 46. North America Immunoassays Sales Market Share by Application (2017-2028)
Figure 47. North America Immunoassays Revenue Market Share by Country (2017-2028)
Figure 48. United States Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Immunoassays Sales Market Share by Type (2017-2028)
Figure 52. Europe Immunoassays Sales Market Share by Application (2017-2028)
Figure 53. Europe Immunoassays Revenue Market Share by Country (2017-2028)
Figure 54. Germany Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Immunoassays Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Immunoassays Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Immunoassays Revenue Market Share by Region (2017-2028)
Figure 62. China Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Immunoassays Sales Market Share by Type (2017-2028)
Figure 69. South America Immunoassays Sales Market Share by Application (2017-2028)
Figure 70. South America Immunoassays Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Immunoassays Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Immunoassays Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Immunoassays Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Immunoassays Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source